[ad_1] New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in early-stage breast cancer and guide long-term treatment decisions […]
[ad_1] IRVING, Texas, Nov. 21, 2024 /PRNewswire/ — Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition, announces that […]
[ad_1] In collaboration with leading cancer centers, research results to be presented from seven studies across a wide range of tumor types demonstrating Caris’ impact on precision medicine IRVING, Texas, Sept. 4, 2024 /PRNewswire/ — […]
[ad_1] IRVING, Texas, Aug. 23, 2024 /PRNewswire/ — Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition, announces […]
